Author: Sylvain LECOMTE

This author has written 14 articles

01/07/2020 : The University of Tours and Theradiag sign two agreements simultaneously: an exclusive licensing agreement for the production of COVID-19 viral proteins and a global collaboration agreement that could lead to the creation of further partnerships

Croissy-Beaubourg, July, 1, 2020, 5:45 pm CEST – The University of Tours and THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for the French PEA-PME personal equity plan), a company specializing in in vitro diagnostics and theranostics,…

Continue Reading01/07/2020 : The University of Tours and Theradiag sign two agreements simultaneously: an exclusive licensing agreement for the production of COVID-19 viral proteins and a global collaboration agreement that could lead to the creation of further partnerships